Europe (WHO region) vs Gambia: Previously treated cases tested for RR-/MDR-TB
Europe (WHO region)
90.0%
in 2024
Gambia
100.0%
in 2024
Europe (WHO region) rank
2nd
Gambia rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Europe (WHO region)
- Gambia
How they compare
Gambia currently reports 100.0% against 90.0% in Europe (WHO region), a difference of 10.0%.
That makes Gambia's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 4 times across 16 shared years of data; in 2006 it was Gambia ahead.
Europe (WHO region) ranks 2nd and Gambia ranks 1st of 11 groups.
Across the 3 decades both report, Europe (WHO region) averaged higher in 2 and Gambia in 1.
Head to head by decade
| Decade | Europe (WHO region) | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 23.2% | 52.8% | 29.5% | Gambia |
| 2010s | 58.3% | 53.6% | 4.7% | Europe (WHO region) |
| 2020s | 93.8% | 89.4% | 4.4% | Europe (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Europe (WHO region) or Gambia?
- Gambia, at 100.0% against 90.0% in Europe (WHO region) as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Europe (WHO region) and Gambia?
- 10.0%, with Gambia ahead.
- How many years of comparable data are there for Europe (WHO region) and Gambia?
- 16 years are reported by both, from 2006 to 2024.
- How do Europe (WHO region) and Gambia rank globally for previously treated cases tested for rr-/mdr-tb?
- Europe (WHO region) ranks 2nd and Gambia ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.